BŞBurcu Öztürk Şahin

Burcu Öztürk Şahin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Burcu Öztürk Şahin has a total of 264 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Frailty, organ dysfunction and mortality in older ICU patients

    by Umut Sabri Kasapoglu, Ozlem Yazicioglu Mocin, Eylem Tuncay, Sinem Gungor, Huseyin Arikan, Ozlem Ediboglu, Nazlı Huma Teke, Eda Macit Aydın, Berkay Kucuk, Dursun Ali Saglam, et al.

  • Open Access

    Use of Impulse Oscillometry in Patients with Chronic Obstructive Pulmonary Disease

    by Burcu Öztürk Şahin, Nurdan Köktürk

    Use of Impulse Oscillometry in Patients with Chronic Obstructive Pulmonary Disease - Thoracic Research and Practice

  • Open Access

    Reliability of Pulmonary Function Tests in Patients with Chronic Obstructive Pulmonary Disease

    by Fatma Arslan, Elif Şen, Burak Şirin, Nurdan Köktürk, Gaye Ulubay, Selma Aydogan Eroglu, Bilun Gemicioglu, Özlem Sönmez, İrEm Şerifoğlu, Asli Gorek Dilektasli, et al.

    Introduction: Chronic Obstructive Pulmonary Disease (COPD) is frequently underdiagnosed due to limited use and suboptimal quality of spirometry. Methods: This multicenter, prospective observational study aimed to assess the quality of spirometry tests in COPD patients across six tertiary care centers in Turkey. A total of 560 spirometry tests were independently evaluated by two pulmonologists, and inter-rater reliability was analyzed using Cohen’s Kappa. Results: The study included 124 women and 436 men, with a mean age of 65.9± 10.2 years. Spirometry patterns were interpreted as obstructive in 79.1% of tests, restrictive in 5.7%, mixed in 2.7%, normal in 6.7%, inconclusive in 5.5%, and as upper airway obstruction in 0.18% of cases (K=0.890). Routine post-bronchodilator testing was performed in 87.14% of the cases, while 12.85% were post-reversibility tests. Graphical data included volume-time curves (88.5%), flow-volume loops (99.6%), and inspiratory limbs (98.7%). Reference values were predominantly based on ECSC (86.4%), followed by GLI (8.9%) and NHANES (0.25%). Mean spirometric values included FEV1 (% predicted) 57.2%, FVC (% predicted) 72.7%, and FEV1/FVC 61.9%. Cough in the first second of FVC was observed in 17 (3%) (K=0.677), variable or insufficient effort 13.4% (K=0.563), mouth leak 1.8% (K=0.305), mouthpiece obstruction 0.5% (K=0.332), rapid expiration 1.8% (K=0.354), increased concavity 83% (K=0.683), and small airway obstruction 87% (K=0.709) were reported by interpreters. Conclusion: Spirometry reports frequently lack key information such as preliminary diagnoses, test indication, technician, and device details. ECSC is the most commonly used reference. Rates of inconclusive and erroneous tests—due to variable or insufficient effort, mouth leak, mouthpiece obstruction, and rapid expiration—are low.


  • Open Access

    Validation Study of Rome Criteria for Assessing COPD Exacerbation Severity and Predicting Clinical Outcomes: Turkish Thoracic Society COPD Assembly

    by Ayse Baha, Caner Baysan, Sibel Nayci, Eylem Ozgur, Tugce Karamustafalioglu, Elif Sen, Elif Selcuk, Gozde Mit, Aylin Alpaydin, Burcu Ozturk, et al.

    Objective: The Rome classification was introduced to assess the severity of acute exacerbation (AE) of chronic obstructive pulmonary disease (COPD) based on easily measurable variables. However, its validation for global use has not yet reached a sufficient level. This study aims to evaluate the validity of the Rome criteria in determining the severity and prognosis of COPD AE in Turkey. Methods: This multicenter study, conducted for the first time in Turkey and for the fourth time worldwide, included 750 patients diagnosed with AE-COPD who presented to emergency departments and outpatient clinics. According to the Rome criteria, patients were classified into three groups: mild, moderate, and severe AE-COPD. Results: The study included 99 (13.2%) patients in the mild, 479 (63.9%) in the moderate, and 172 (22.9%) in the severe group. Emergency visits, hospitalizations, and ICU admissions in the past year were more frequent in the moderate and severe groups (p < 0.001 for all comparisons). Regarding outcomes of emergency or outpatient visits, most mild exacerbation cases were discharged (p < 0.001), while most moderate and severe exacerbations required hospitalization (p < 0.001). Compared to the moderate group, the severe exacerbation group had a higher risk of ICU admission (p < 0.001), NIV (p < 0.001), IMV (p < 0.001), in-hospital mortality (p < 0.001), and 30-day mortality (p = 0.015). No significant differences were found in 90-day mortality or 30 and 90-day readmission rates (p = 0.258, p = 0.712, p = 0.681, respectively). Survival analysis revealed no significant difference between the moderate and severe groups (p = 0.764). Conclusion: The findings suggest that the Rome criteria can be successfully used to assess exacerbation severity in AE-COPD patients presenting to secondary and tertiary care hospitals in Turkey.


  • A rare complication developing after endobronchial ultrasonography-guided transbronchial needle aspiration: Pneumomediastinum

    by Burcu Öztürk Şahi̇n, Nesrin Öcal, Cantürk Taşçi, Yakup Arslan, Beste Arikan, Deniz Doğan

  • Cough burden and quality of life in patients with progressive pulmonary fibrosis: A multicenter observational study

    by Aykut Cilli, Fatih Uzer, Sevda Sener Comert, Nesrin Ocal, Dildar Duman, Elif Yelda Özgün Niksarlıoğlu, Necmiye Funda Coşkun, Ahmet Ursavaş, Ismail Hanta, Emsal Sema Altınoz, et al.


  • Open Access

    Readmission rates within the first 30 and 90 days after severe COPD exacerbations (RACE study)

    by Oya Baydar Toprak, Mehmet Polatli, Ayşe Baha, Nurdan Kokturk, Dilek Yapar, Secil Ozkan, Elif Sen, Fatma Ciftci, Burcu Ozturk, Sumeyye Kodalak, et al.

    Chronic obstructive pulmonary disease (COPD) frequently results in hospital readmission and contributes to increased morbidity and mortality. This multicenter prospective study aimed to identify factors that increase the risk of readmission within 30 to 90 days of severe COPD exacerbation. A total of 415 patients admitted to the emergency department (ED) or general pulmonology ward after discharge due to severe exacerbations from 13 tertiary centers in Turkey were included. Of the participants, 346 (83.4%) were male and 69 (16.6%) were female, with an average age of 69.0 ± 9.1 years. Readmissions within 30 and 90 days after the initial hospitalization occurred in 176 (42.4%) and 191 (46%) patients, respectively. Prospective data collection focused on exacerbation severity, disease severity, and the utility of initial admissions. Factors for 30 to 90 day readmission were analyzed using univariate and multivariate regression models. A 30-day readmission correlated significantly with Hospital Anxiety Depression Scale scores above 16 [odds ratio [OR] 95% confidence intervals [CI]: 1.9 (1.1–3.6); P = .042], severe exacerbation history in the previous year [OR 95% CI: 1.7 (1.1–2.9); P = .038], hospital-acquired pneumonia [OR 95% CI: 1.9 (1–4.1); P = .049)], and frequent antibiotic use in the previous year [OR 95% CI: 1.8 (1.2–2.7); P = .007]. Risk factors for 90-day readmissions included: Grades 3 to 4 tricuspid regurgitation [OR 95% CI: 2.2 (1.1–4.4); P = .024], 2 or more moderate COPD exacerbations [OR 95% CI: 1.9 (1.2–3.1); P = .010], severe exacerbation history in the previous year [OR 95% CI: 2.5 (1.5–4.2); P = .001], immunosuppression [OR 95% CI: 2.7 (1.2–5.7); P = .013], frequent antibiotic use the previous year [OR 95% CI: 1.5 (1–2.4); P = .048], hospitalization via the ED [OR 95% CI: 1.6 (1.1–2.6); P = .028]. To mitigate complications and readmissions, patients with a history of frequent severe COPD exacerbations, high anxiety and depression scores, frequent antibiotic requirements, immunosuppression, tricuspid regurgitation, hospital-acquired pneumonia, and those admitted to the ED should be prioritized for remote monitoring after initial discharge.


  • Open Access

    Factors Associated with Increasing Costs in Severe Chronic Obstructive Pulmonary Disease Exacerbation: Turkish Thoracic Society Chronic Obstructive Pulmonary Disease Assembly

    by Ayşe Baha, Nurdan Köktürk, Caner Baysan, Burcu Öztürk, Sümeyye Kodalak Cengiz, Yelda Varol, Aydan Mertoğlu, Ali Kadri Çırak, Onur Turan, Neşe Dursunoğlu, et al.

    COPD,severe exacerbation,costs,discharge,antibiotic,nutrition,pulmonary rehabilitation


  • Open Access

    Risk factors for post-acute sequelae of COVID-19 in hospitalized patients: An observational study based on a survey in a tertiary care center in Türkiye

    by Yeşim Yıldız, Burcu Öztürk Şahin, Mert Can Taşdemir, Şerife Demir, Beyza Çiftci, Nurdan Köktürk, Tansu Ulukavuk Çiftçi, Ahmet Selim Yurdakul, Nilgün Yılmaz Demirci, Müge Aydoğdu, et al.

    Introduction: Long COVID is a multisystem disease with various symptoms and risk factors. We aim to investigate the post-acute sequelae of COVID-19 and related risk factors in a tertiary care center.Materials and Methods: In this observational study, based on a survey of 1.977 COVID-19 patients hospitalized from April 2020 to January 2021, a retrospective assessment was carried out on 1.050 individuals who were reachable via telephone to determine their eligibility for meeting the inclusion criteria.Results: The data of 256 patients who reported at least one persistent symptom were analyzed. Long COVID prevalence was 24.3%. Among 256 patients (median age 52.8; 52.7% female; 56.63% had at least one comorbidity), dyspnea, fatigue, arthralgia-myalgia, cough, and back pain were the most common post-acute sequelae of COVID-19 (42.4%; 28.29%; 16.33%; 13.15% and 7.17%, respectively). The risk factors for the persistence of dyspnea included having lung diseases such as chronic obstructive pulmonary disease, a history of intensive care support, the requirement for long-term oxygen therapy, and a history of cytokine storm (p= 0.024, p= 0.026, p< 0.001, p= 0.036, p= 0.005, respectively). The correlation between lung involvement with post-discharge cough (p= 0.041) and dizziness (p= 0.038) was significant. No correlation between the symptoms with the severity of acute infection, age, and gender was found. When a multivariate regression analysis was conducted on the most common long COVID-related symptoms, several independent risk factors were identified. These included having lung disease for dyspnea (OR 5.81, 95% CI 1.08-31.07, p= 0.04); length of hospital stay for myalgia (OR 1.034, 95% CI 1.004-1.065, p= 0.024); and pulmonary involvement of over 50% during COVID-19 infection for cough (OR 3.793, 95% CI 1.184-12.147, p= 0.025).Conclusion: COVID-19 survivors will require significant healthcare services due to their prolonged symptoms. We hope that our findings will guide the management of these patients in clinical settings towards best practices.


  • Open Access

    Granulomatous Mediastinitis: A Rare Cause of Pulmonary Hypertension

    by Burcu Ozturk Sahin, Zuheyla Galata, Serife Demir, Nilgun Yilmaz Demirci, Gulten Tacoy, Gonca Erbas, Ipek Isil Gonul, Lutfiye Ozlem Atay, I. Kivilcim Oguzulgen

    Anthracosis,anthracofibrosis,fibrosis mediastinitis,biomass exposure,pulmonary hypertension